|
Sep 24
|
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual Meeting
|
|
Sep 10
|
United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind—Ever
|
|
Aug 30
|
United Therapeutics Shares Thrive
|
|
Aug 30
|
United Therapeutics (UTHR) Up 9.9% Since Last Earnings Report: Can It Continue?
|
|
Aug 28
|
United Therapeutics Corporation's (NASDAQ:UTHR) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
|
|
Aug 28
|
United Therapeutics Corporation to Present at Upcoming Investor Conferences
|
|
Jul 30
|
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
|
|
Jul 26
|
Implied Volatility Surging for United Therapeutics (UTHR) Stock Options
|
|
Jul 25
|
Will PTC Therapeutics (PTCT) Report Negative Q2 Earnings? What You Should Know
|
|
Jul 24
|
United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024
|
|
Jul 11
|
United Therapeutics (UTHR) Completes Enrolment in IPF Study
|
|
Jul 11
|
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
|
|
Jul 11
|
United Therapeutics’ TETON 2 study achieves full enrolment for IPF treatment
|
|
Jul 10
|
United Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis
|
|
Jun 27
|
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
|
|
Jun 27
|
United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors
|
|
Jun 26
|
Why United Therapeutics, An IBD 50 Stock, Has Surged 36% Over Nine Weeks
|
|
Jun 26
|
Here's Why United Therapeutics (UTHR) is a Strong Value Stock
|
|
Jun 17
|
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
|
|
Jun 11
|
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
|